NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our results show that treatment with either extract interrupts the vicious cycle of CML-mediated RAGE/NF-κB activation by decreasing protein glycation and CML formation in both tissues, indicating that both examined extracts express strong antiglycating activity in vivo.